Company

01

Yuyu Pharma's New Growth Engine

Yuyu Pharma has identified the animal industry as its next-generation growth engine. The animal industry is becoming a global growth driver, fueled by advances in biopharmaceutical technology, the expansion of sustainable aquaculture, and rising demand for high-quality pet care. We are building an animal industry portfolio spanning veterinary biologics, sustainable food system technologies, next-generation pet wellness, and community models.

02

Commitment to Strategic Investment

Yuyu Pharma's animal industry portfolio is built through Yuyu Venture Studio, a dedicated platform organization designed to identify opportunities in next-generation healthcare and adjacent fields and to make strategic investments. Yuyu Venture Studio establishes startups, makes selective strategic investments, and incubates high-growth ventures. It serves as a forward base for global expansion, particularly in the U.S. market, with the goal of proactively building the foundation for Yuyu Pharma's mid- to long-term growth and securing strategic leadership in the global healthcare market.

03

Pet Healthcare

Yuyu Pharma has made strategic investments by establishing Yuyu Bio, which develops biopharmaceuticals for companion animals, and Mervyn's Petcare, which operates a health functional food business for pets. Additionally, the company has invested in VETMAB BIOSCIENCES, a developer of species-specific monoclonal antibodies (mAb) for companion animals; DOG PPL, a pet community and wellness platform; and Dalan Animal Health, which contributes to the global food system by developing vaccines for honeybees and shrimp.